FABP4 transports fatty acids and it has been proven to participate in obesity linked diseases, as well as being considered a biomarker of metabolic syndrome. We obtained the Raman spectrum at different concentrations for non-invasive future detection in tissues involved in metabolic syndrome.

© 2020 The Author(s)

PDF Article


You do not have subscription access to this journal. Citation lists with outbound citation links are available to subscribers only. You may subscribe either as an OSA member, or as an authorized user of your institution.

Contact your librarian or system administrator
Login to access OSA Member Subscription

Supplementary Material (1)

» Media 1: PDF (481 KB)